, France. 3 INSERM U1153 -Equipe de recherche en Epidémiologie Obstétricale, Périnatale et Pédiatrique (EPOPé) centre de Recherche Epidémiologie et Statistique Sorbonne Paris Cité (CRESS)

H. Service-de-cytogénétique and . Cochin, Groupe Hospitalier Cochin-Broca-Hôtel Dieu

A. Service-de-d'histologie and . Béclère, , 2018.

, References 1. Cabrol S. Turner syndrome, Ann Endocrinol, vol.68, issue.1, pp.2-9, 2007.

S. Cabrol, C. Saab, M. Gourmelen, M. C. Raux-demay, L. Bouc et al., Turner syndrome: spontaneous growth of stature, weight increase and accelerated bone maturation, Arch Pediatr, vol.3, issue.4, pp.313-321, 1996.

M. B. Ranke, H. Pfluger, W. Rosendahl, P. Stubbe, H. Enders et al., Turner syndrome: spontaneous growth in 150 cases and review of the literature, Eur J Pediatr, vol.141, issue.2, pp.81-89, 1983.

A. Linglart, S. Cabrol, P. Berlier, C. Stuckens, K. Wagner et al., Growth hormone treatment before the age of 4 years prevents short stature in young girls with turner syndrome, Eur J Endocrinol, vol.164, issue.6, pp.891-898, 2011.

D. A. Price and M. B. Ranke, Growth hormone in turner syndrome, Arch Dis Child, vol.84, issue.6, p.525, 2001.

M. B. Ranke, Why treat girls with turner syndrome with growth hormone? Growth and beyond, Pediatr Endocrinol Rev, vol.12, issue.4, pp.356-65, 2015.

J. Ross, P. A. Lee, R. Gut, and J. Germak, Impact of age and duration of growth hormone therapy in children with turner syndrome, Horm Res Paediatr, vol.76, issue.6, pp.392-401, 2011.

M. Bruandet, N. Molko, L. Cohen, and S. Dehaene, A cognitive characterization of dyscalculia in turner syndrome, Neuropsychologia, vol.42, issue.3, pp.288-98, 2004.

M. L. Collaer, M. E. Geffner, F. R. Kaufman, B. Buckingham, and M. Hines, Cognitive and behavioral characteristics of turner syndrome: exploring a role for ovarian hormones in female sexual differentiation, Horm Behav, vol.41, issue.2, pp.139-55, 2002.

J. L. Ross, G. A. Stefanatos, H. Kushner, A. Zinn, C. Bondy et al., Persistent cognitive deficits in adult women with turner syndrome, Neurology, vol.58, issue.2, pp.218-243, 2002.

M. B. Ranke and P. Saenger, Turner's syndrome, Lancet, vol.358, issue.9278, pp.309-323, 2001.

C. Ankarberg-lindgren, M. Elfving, K. A. Wikland, and E. Norjavaara, Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls, J Clin Endocrinol Metab, vol.86, issue.7, pp.3039-3083, 2001.

E. M. Bannink, H. Raat, P. G. Mulder, and S. M. De-muinck-keizer-schrama, Quality of life after growth hormone therapy and induced puberty in women with turner syndrome, J Pediatr, vol.148, issue.1, pp.95-101, 2006.

E. M. Bannink, C. Van-sassen, S. Van-buuren, F. H. De-jong, M. Lequin et al., Puberty induction in turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels, Clin Endocrinol, vol.70, issue.2, pp.265-73, 2009.

S. Piippo, H. Lenko, P. Kainulainen, and I. Sipila, Use of percutaneous estrogen gel for induction of puberty in girls with turner syndrome, J Clin Endocrinol Metab, vol.89, issue.7, pp.3241-3248, 2004.

P. Saenger, K. A. Wikland, G. S. Conway, M. Davenport, C. H. Gravholt et al., Recommendations for the diagnosis and management of turner syndrome, J Clin Endocrinol Metab, vol.86, issue.7, pp.3061-3070, 2001.

B. Donadille, A. Rousseau, D. Zenaty, S. Cabrol, C. Courtillot et al., Cardiovascular findings and management in turner syndrome: insights from a French cohort, Eur J Endocrinol, vol.167, issue.4, pp.517-539, 2012.

M. El-mansoury, M. L. Barrenas, I. Bryman, C. Hanson, C. Larsson et al., Chromosomal mosaicism mitigates stigmata and cardiovascular risk factors in turner syndrome, Clin Endocrinol, vol.66, issue.5, pp.744-51, 2007.

M. El-mansoury, I. Bryman, K. Berntorp, C. Hanson, L. Wilhelmsen et al., Hypothyroidism is common in turner syndrome: results of a five-year follow-up, J Clin Endocrinol Metab, vol.90, issue.4, pp.2131-2136, 2005.

M. Elsheikh, J. A. Wass, and G. S. Conway, Autoimmune thyroid syndrome in women with Turner's syndrome--the association with karyotype, Clin Endocrinol, vol.55, issue.2, pp.223-229, 2001.

K. Landin-wilhelmsen, I. Bryman, M. Windh, and L. Wilhelmsen, Osteoporosis and fractures in turner syndrome-importance of growth promoting and oestrogen therapy, Clin Endocrinol, vol.51, issue.4, pp.497-502, 1999.

P. Mikosch, H. J. Gallowitsch, E. Kresnik, and P. Lind, Osteoporosis in Turner syndrome with chromosomal mosaicism (45,XO/46,XY). A case report, Wien Med Wochenschr, vol.150, issue.12, pp.262-267, 2000.

K. Rubin, Turner syndrome and osteoporosis: mechanisms and prognosis, Pediatrics, vol.102, issue.2, pp.481-486, 1998.

F. Perrotin, A. Guichet, H. Marret, J. Potin, G. Body et al., Prenatal outcome of sex chromosome anomalies diagnosed during pregnancy: a retrospective study of 47 cases, J Gynecol Obstet Biol Reprod (Paris), vol.29, issue.7, pp.668-76, 2000.

P. A. Boyd, M. Loane, E. Garne, B. Khoshnood, H. Dolk et al., Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy, Eur J Hum Genet, vol.19, issue.2, pp.231-235, 2011.

J. L. Brun, F. Gangbo, Z. Q. Wen, K. Galant, L. Taine et al., Prenatal diagnosis and management of sex chromosome aneuploidy: a report on 98 cases, Prenat Diagn, vol.24, issue.3, pp.213-221, 2004.

S. M. Christian, D. Koehn, R. Pillay, A. Macdougall, and R. D. Wilson, Parental decisions following prenatal diagnosis of sex chromosome aneuploidy: a trend over time, Prenat Diagn, vol.20, issue.1, pp.37-40, 2000.

E. Garne, B. Khoshnood, M. Loane, P. Boyd, H. Dolk et al., Termination of pregnancy for fetal anomaly after 23 weeks of gestation: a European register-based study, BJOG, vol.117, issue.6, pp.660-666, 2010.

, Legislation in Europe. IPPF. International Planned Parenthood Federation, 2012.

, Recommandations Professionnelles de l'Agence de la Biomédecine pour le fonctionnement des Centres Pluridisciplinaires de Diagnostic Prénatal (CPDPN), 2012.

B. Khoshnood, C. De-vigan, V. Vodovar, J. Goujard, A. Lhomme et al., Trends in antenatal diagnosis, pregnancy termination and perinatal mortality in infants with congenital heart disease: evaluation in the general population of Paris, J Gynecol Obstet Biol Reprod, vol.35, issue.5, pp.455-64, 1983.

N. Gruchy, F. Vialard, M. Decamp, A. Choiset, A. Rossi et al., Pregnancy outcomes in 188 French cases of prenatally diagnosed Klinefelter syndrome, Hum Reprod, vol.26, issue.9, pp.2570-2575, 2011.

J. Chamberlain, P. Rogers, J. L. Price, S. Ginks, B. E. Nathan et al., Validity of clinical examination and mammography as screening tests for breast cancer, Lancet, vol.2, issue.7943, pp.1026-1056, 1975.

J. M. Grant, The fetal heart rate trace is normal, isn't it? Observer agreement of categorical assessments, Lancet, vol.337, issue.8735, pp.215-223, 1991.

B. Khoshnood, D. Vigan, C. Vodovar, V. Goujard, J. Lhomme et al., Trends in prenatal diagnosis, pregnancy termination, and perinatal mortality of newborns with congenital heart disease in France, Pediatrics, vol.115, issue.1, pp.95-101, 1983.
URL : https://hal.archives-ouvertes.fr/inserm-00108256

, Publisher's Note

, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations